Ciclopiroxolamine cream for treating seborrheic dermatitis: A double-blind parallel group comparison

Infection

Volumn 30, Issue 6, 2002, Pages 373-377

  Unholzer, A ^a   Varigos, G ^b   Nicholls, D ^d   Schinzel, S ^c   Nietsch, K H ^c   Ulbricht, H ^c   Korting, Hans Christian ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CICLOPIROXOLAMINE;

ADULT; ARTICLE; AUSTRALIA; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; FACE INJURY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEW ZEALAND; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEBORRHEIC DERMATITIS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; DERMATITIS, SEBORRHEIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OINTMENTS; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; PYRIDONES;

EID: 0036456968     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-002-2196-9     Document Type: Article

References (18)

1. Peter RU, Richarz-Barthauer U: Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: Results of a multicentre, double-blind, placebo-controlled trial. Br J Dermatol 1995; 132: 441-445.
2. Ortonne JP, Lacour JP, Vitetta A, Le Fichoux Y: Comparative study of ketoconazole 2% foaming gel and betamethasone dipropionate 0.05% lotion in the treatment of seborrhoeic dermatitis in adults. Dermatology 1992; 184: 275-280.
3. McGrath J, Murphy GM: The control of seborrhoeic dermatitis and dandruff by antipityrosporal drugs. Drugs 1991; 41: 178-184.
4. Hay RJ, Graham-Brown RA: Dandruff and seborrhoeic dermatitis: Causes and management. Clin Exp Dermatol 1997; 22: 3-6.
5. Mathes BN, Douglass MC: Seborrhoeic dermatitis in patients with AIDS. J Am Acad Dermatol 1985; 13: 947-951.
6. McGinley KJ, Leyden JJ, Marples RR, Kligman AM: Quantitative microbiology of the scalp in non-dandruff, dandruff and seborrhoeic dermatitis. J Invest Dermatol 1975; 64: 401-405.
7. Faergemann J: Propylene glycol in the treatment of seborrhoeic dermatitis of the scalp: A double-blind study. Cutis 1988; 42: 69-71.
8. Sei Y, Hamaguchi T, Ninomiya J, Nakabayashi A, Takiuchi I: Seborrhoeic dermatitis: Treatment with anti-mycotic agents. J Dermatol 1994; 21: 334-340.
9. Faergemann J: Seborrhoeic dermatitis and Pityrosporum orbiculare: Treatment of seborrhoeic dermatitis of the scalp with miconazole-hydrocortisone (Daktacort), miconazole and hydrocortisone. Br J Dermatol 1986; 114: 695-700.
10. Faergemann J: Treatment of seborrhoeic dermatitis with bifonazole. Mycoses 1989; 32: 309-311.
11. Peter RU, Korting HC: Behandlung des seborrhoischen ekzems mit ketoconazol im vergleich zu einer wirkstoff-freien pflegecreme. Arzneimittelforschung 1991; 41: 852-854.
12. Zienicke H, Korting HC, Braun-Falco O, Effendy I, Hagedorn M, Küchmeister B, Meisel C: Comparative efficacy and safety of bifonazole 1% cream and the corresponding base preparation in the treatment of seborrhoeic dermatitis. Mycoses 1993; 36: 325-331.
13. Nenoff P, Haustein UF: Der effekt anti-seborrhoischer substanzen gegen pityrosporum ovale in vitro. Hautarzt 1994; 45: 464-467.
14. Dupuy P, Maurette C, Amoric JC, Chosidow O: Randomized, placebo-controlled, double-blind study on clinical efficacy of ciclopiroxolamine 1 % cream in facial seborrhoeic dermatitis. Br J Dermatol 2001; 144: 1033-1037.
15. Van Elteren PH: On the combination of independent two-sample tests of Wilcoxon. Bulletin of the International Statistical Institute 1960; 37: 351-361.
16. Lehmann EL: Nonparametrics: Statistical Methods Based on Rank. Holden-Day, San Francisco 1975, pp 132-137.
17. Korting HC, Grundmann-Kollmann M: The hydroxypyridones: A class of antimycotics of its own. Mycoses 1997; 40: 243-247.
18. Goitre M, Bedello PG, Cane D, Pulatti P, Forte M, Cervetti O: Contact dermatitis due to ciclopiroxolamine. Contact Dermatitis 1986; 15: 94-95.